Question 1

What is Allogene's product pipeline?

Accepted Answer

Allogene's product pipeline includes their flagship product, Allo-CAR T™, which is an investigational allogeneic CAR T therapy. The company is also working on a range of other cell therapy products for the treatment of various types of cancer.

Question 2

What is Allogene's approach to cell therapy?

Accepted Answer

Allogene is focused on developing "off-the-shelf" cell therapy products, which can be made available to patients on-demand, unlike traditional autologous CAR T therapies that require the patient's own cells to be harvested, modified, and then reinfused. This approach has the potential to make cell therapy more accessible and scalable.

Question 3

What is Allogene's background and expertise?

Accepted Answer

Allogene was founded by a team of industry leaders with extensive experience in the development of cell therapies. The company's management team and scientific advisors have a proven track record in the field of cancer immunotherapy and cell therapy.

Question 4

How does Allogene approach corporate responsibility and sustainability?

Accepted Answer

Allogene is committed to responsible and sustainable business practices. The company has an ESG (Environmental, Social, and Governance) report that outlines its efforts in areas such as diversity and inclusion, environmental impact, and ethical governance.

Allogene Therapeutics

Company Overview

Company Name

Address

Website

Employees

About Allogene Therapeutics

Frequently Asked Questions about Allogene Therapeutics

What is Allogene's product pipeline?

What is Allogene's approach to cell therapy?

What is Allogene's background and expertise?

How does Allogene approach corporate responsibility and sustainability?

Technologies Used

Social Profiles

Key Decision Makers